AGL 38.00 No Change ▼ 0.00 (0%)
AIRLINK 136.02 Decreased By ▼ -0.43 (-0.32%)
BOP 5.43 Decreased By ▼ -0.01 (-0.18%)
CNERGY 3.80 No Change ▼ 0.00 (0%)
DCL 7.50 No Change ▼ 0.00 (0%)
DFML 45.40 Decreased By ▼ -0.01 (-0.02%)
DGKC 78.65 Increased By ▲ 0.13 (0.17%)
FCCL 29.05 Increased By ▲ 0.16 (0.55%)
FFBL 56.80 Decreased By ▼ -0.20 (-0.35%)
FFL 9.19 Decreased By ▼ -0.08 (-0.86%)
HUBC 99.20 Increased By ▲ 2.40 (2.48%)
HUMNL 13.25 Decreased By ▼ -0.15 (-1.12%)
KEL 3.75 Decreased By ▼ -0.02 (-0.53%)
KOSM 7.29 Increased By ▲ 0.01 (0.14%)
MLCF 37.60 Decreased By ▼ -0.20 (-0.53%)
NBP 66.80 Decreased By ▼ -0.70 (-1.04%)
OGDC 167.00 Decreased By ▼ -0.52 (-0.31%)
PAEL 25.07 Decreased By ▼ -0.03 (-0.12%)
PIBTL 6.75 Increased By ▲ 0.05 (0.75%)
PPL 131.04 Decreased By ▼ -0.46 (-0.35%)
PRL 25.30 Decreased By ▼ -1.10 (-4.17%)
PTC 14.93 Decreased By ▼ -0.17 (-1.13%)
SEARL 61.61 Decreased By ▼ -0.64 (-1.03%)
TELE 6.97 Decreased By ▼ -0.03 (-0.43%)
TOMCL 36.51 Increased By ▲ 0.28 (0.77%)
TPLP 7.74 Decreased By ▼ -0.14 (-1.78%)
TREET 14.05 Increased By ▲ 0.05 (0.36%)
TRG 45.00 Increased By ▲ 0.45 (1.01%)
UNITY 26.06 Increased By ▲ 0.21 (0.81%)
WTL 1.22 No Change ▼ 0.00 (0%)
BR100 9,143 Decreased By -0.1 (-0%)
BR30 27,318 Decreased By -7.7 (-0.03%)
KSE100 85,538 Decreased By -47.6 (-0.06%)
KSE30 26,924 Decreased By -59.9 (-0.22%)
Pakistan

Interior Minister Ijaz Shah gets first dose of COVID-19 trial vaccine

  • UHS Vice-Chancellor Prof Javed Akram says the minister’s staff members were also administered the trial vaccine
  • China had supplied the medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement
Published December 7, 2020

(Karachi) Federal Interior Minister Ijaz Shah has been administered trial vaccine of COVID-19 from China at the University of Health Sciences (UHS) Lahore, local media reported on Monday.

“Interior Minister Ijaz Shah was administered the vaccine, which has been in phase three of clinical trials,” UHS Vice-Chancellor Prof Dr Javed Akram said.

“The minister’s staff members were also administered the trial vaccine,” Prof Akram added.

Earlier, Pakistan began final-phase testing of a Chinese-made vaccine against novel coronavirus, the first ever clinical trial of its kind in the South Asian nation.

China had supplied the COVID-19 medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement.

So far, the trial vaccine has seen a positive public response, raising the hope that the effort would meet its target. The specific vaccine has already established its safety and efficacy in the previous trials held in China with no serious adverse effects.

It’s now being tested on a wider population in Russia, Mexico, Chile, Argentina, Saudi Arabia and Pakistan; the country has been allocated 8,000 recruits out of a total of 40,000 and is currently conducting the trial at five centres in Islamabad, Lahore and Karachi.

Comments

Comments are closed.